Obstructive sleep apnea (OSA) is a sleep-related respiratory disorder with a reduction or obstruction of total air flow despite continuous efforts with patents to breathe. The prevalence of OSA is around 2-4% in men and 1-2% in women. The American Academy of Pediatric Dentistry (AAPD) recognizes that obstructive sleep apnea (OSA) occurs in a pediatric population. Oral myofunctional therapy has emerged as an alternative treatment that allows for obstructive sleep apnea (OSA). The aim of this study is to systematically review the literature on oral myofunctional therapy for future care in children with obstructive sleep apnea (OSA). Data source of Web of Science, Scopus, and The Cochrane Library. Studies published from 2011 to 2020 that evaluate treatments with isolated oral myofunctional therapy in subjects with OSA. Sixty articles were assessed, including 60 articles from an electronic database, 50 records were filtered, 30 records were issued, 22 full-text articles were assessed for eligibility and 10 full-text articles were included. All of these articles say that myofunctional therapy has the potential to be an option for OSA treatment. Therefore a systematic literature review shows that oral myofunctional therapy for future treatment of obstructive sleep apnea in children (OSA).
Obstructive Sleep Apnea; Myofunctional Therapy; Pediatric